These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1484 related articles for article (PubMed ID: 32134116)
1. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. Wang Y; Wang Y; Chen Y; Qin Q J Med Virol; 2020 Jun; 92(6):568-576. PubMed ID: 32134116 [TBL] [Abstract][Full Text] [Related]
2. [Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future]. Ye ZW; Jin DY Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):571-592. PubMed ID: 32347053 [TBL] [Abstract][Full Text] [Related]
3. The novel zoonotic COVID-19 pandemic: An expected global health concern. Contini C; Di Nuzzo M; Barp N; Bonazza A; De Giorgio R; Tognon M; Rubino S J Infect Dev Ctries; 2020 Mar; 14(3):254-264. PubMed ID: 32235085 [TBL] [Abstract][Full Text] [Related]
4. Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review. Liya G; Yuguang W; Jian L; Huaiping Y; Xue H; Jianwei H; Jiaju M; Youran L; Chen M; Yiqing J APMIS; 2020 Jun; 128(6):423-432. PubMed ID: 32363707 [TBL] [Abstract][Full Text] [Related]
5. Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks. Wooding DJ; Bach H Clin Microbiol Infect; 2020 Oct; 26(10):1436-1446. PubMed ID: 32791241 [TBL] [Abstract][Full Text] [Related]
6. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2. Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096 [TBL] [Abstract][Full Text] [Related]
7. A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus-A possible reference for coronavirus disease-19 treatment option. Yao TT; Qian JD; Zhu WY; Wang Y; Wang GQ J Med Virol; 2020 Jun; 92(6):556-563. PubMed ID: 32104907 [TBL] [Abstract][Full Text] [Related]
8. Facing the COVID-19 outbreak: What should we know and what could we do? Yang Y; Shang W; Rao X J Med Virol; 2020 Jun; 92(6):536-537. PubMed ID: 32091134 [No Abstract] [Full Text] [Related]
9. The emergence of a novel coronavirus (SARS-CoV-2) disease and their neuroinvasive propensity may affect in COVID-19 patients. Yashavantha Rao HC; Jayabaskaran C J Med Virol; 2020 Jul; 92(7):786-790. PubMed ID: 32320066 [TBL] [Abstract][Full Text] [Related]
10. Overview of lethal human coronaviruses. Chen B; Tian EK; He B; Tian L; Han R; Wang S; Xiang Q; Zhang S; El Arnaout T; Cheng W Signal Transduct Target Ther; 2020 Jun; 5(1):89. PubMed ID: 32533062 [TBL] [Abstract][Full Text] [Related]
11. A systematic review of SARS-CoV-2 vaccine candidates. Dong Y; Dai T; Wei Y; Zhang L; Zheng M; Zhou F Signal Transduct Target Ther; 2020 Oct; 5(1):237. PubMed ID: 33051445 [TBL] [Abstract][Full Text] [Related]
12. Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19. Halaji M; Farahani A; Ranjbar R; Heiat M; Dehkordi FS Infez Med; 2020 Jun; 28(suppl 1):6-17. PubMed ID: 32532933 [TBL] [Abstract][Full Text] [Related]
15. Scientific research progress of COVID-19/SARS-CoV-2 in the first five months. Li H; Liu Z; Ge J J Cell Mol Med; 2020 Jun; 24(12):6558-6570. PubMed ID: 32320516 [TBL] [Abstract][Full Text] [Related]
16. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? Peeri NC; Shrestha N; Rahman MS; Zaki R; Tan Z; Bibi S; Baghbanzadeh M; Aghamohammadi N; Zhang W; Haque U Int J Epidemiol; 2020 Jun; 49(3):717-726. PubMed ID: 32086938 [TBL] [Abstract][Full Text] [Related]
17. COVID-19, SARS and MERS: are they closely related? Petrosillo N; Viceconte G; Ergonul O; Ippolito G; Petersen E Clin Microbiol Infect; 2020 Jun; 26(6):729-734. PubMed ID: 32234451 [TBL] [Abstract][Full Text] [Related]
18. COVID-19: Transmission, prevention, and potential therapeutic opportunities. Lotfi M; Hamblin MR; Rezaei N Clin Chim Acta; 2020 Sep; 508():254-266. PubMed ID: 32474009 [TBL] [Abstract][Full Text] [Related]
19. The Wuhan SARS-CoV-2-What's next for China. Lu H; Stratton CW; Tang YW J Med Virol; 2020 Jun; 92(6):546-547. PubMed ID: 32115732 [No Abstract] [Full Text] [Related]
20. Potential Maternal and Infant Outcomes from (Wuhan) Coronavirus 2019-nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections. Schwartz DA; Graham AL Viruses; 2020 Feb; 12(2):. PubMed ID: 32050635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]